Sensus Healthcare, Inc. (SRTS)
Data as of , from SEC Form 4 filings.
See up to 3 months of SRTS. The 7-day demo opens the 1M and 3M ranges and puts SRTS on your watchlist.
Start 7-day demoLatest SRTS insider trades
About Sensus Healthcare, Inc. (SRTS)
The SEC lists Sensus Healthcare, Inc. under CIK 0001494891, in surgical and medical instruments and apparatus. We track it alongside the rest of the Health Care sector.
SRTS Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 8 | 171,171 | $564K |
SRTS insider transactions (Form 4)
2321 Form 4 filings on record, the earliest from Dec 19, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Eric Sachetta - Director | Open-market purchase | Common Stock | 37,537 | $3.44 | $129K | |
| Eric Sachetta - Director | Open-market purchase | Common Stock | 27,304 | $3.54 | $97K | |
| Eric Sachetta - Director | Open-market purchase | Common Stock | 9,708 | $3.29 | $32K | |
| Eric Sachetta - Director | Open-market purchase | Common Stock | 10,925 | $3.18 | $35K | |
| Eric Sachetta - Director | Open-market purchase | Common Stock | 34,697 | $3.25 | $113K | |
| Joseph C. Sardano - Officer | Open-market purchase | Common Stock | 20,000 | $3.02 | $60K | |
| Eric Sachetta - Director | Open-market purchase | Common Stock | 24,000 | $3.13 | $75K | |
| Eric Sachetta - Director | Open-market purchase | Common Stock | 7,000 | $3.25 | $23K | |
| Eric Sachetta | Open-market purchase | Common Stock | 1,500 | $3.34 | $5K | |
 Javier Rampolla - Officer | Tax withholding / forfeiture | Common Stock | 3,935 | $10.51 | $41K | |
| Magdalena Martinez - Officer | Tax withholding / forfeiture | Common Stock | 741 | $2.66 | $2K | |
| Eric Sachetta | Open-market purchase | Common Stock | 2,000 | $3.81 footnote F1 | $8K | |
| ||||||
 Michael Sardano - Officer | Grant or award | Common Stock | 40,000 footnote F1 | $0.00 | - | |
| ||||||
| Eric Sachetta | Open-market purchase | Common Stock | 7,000 | $3.93 | $28K | |
| Eric Sachetta | Open-market purchase | Common Stock | 2,500 | $4.50 | $11K | |
| Michael Sardano - Officer | Open-market purchase | Common Stock | 1,000 | $3.80 | $4K | |
| Joseph C. Sardano - Officer | Open-market purchase | Common Stock | 25,000 | $4.03 footnote F1 | $101K | |
| ||||||
| Michael Sardano - Officer | Open-market purchase | Common Stock | 1,000 | $4.26 | $4K | |
| Michael Sardano - Officer | Open-market purchase | Common Stock | 1,000 | $3.37 | $3K | |
| William H. McCall | Grant or award | Common Stock | 20,000 | $0.00 | - | |
| Megan Cornish | Grant or award | Common Stock | 20,000 | $0.00 | - | |
| Michael Sardano - Officer | Grant or award | Common Stock | 40,000 | $0.00 | - | |
| Anthony Benedict Petrelli | Grant or award | Common Stock | 20,000 | $0.00 | - | |
SRTS insider trading FAQ
What is the latest insider trade for SRTS?
Sensus Healthcare, Inc. (SRTS) had 5 insider filings in the last 90 days, with the most recent on 2026-08-31. The full record for SRTS runs to 21 Form 4 filings, the earliest from 2024-12-19. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SRTS stock?
8 insider purchases of SRTS were filed in the last 90 days, totaling $564K.
How many insiders are selling SRTS stock?
No insider sales of SRTS were filed in the last 90 days.
Where can I see SRTS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SRTS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Eric Sachetta view on EDGAR
- - Eric Sachetta view on EDGAR
- - Eric Sachetta view on EDGAR
- - Joseph C. Sardano view on EDGAR
- - Eric Sachetta view on EDGAR
- - Eric Sachetta view on EDGAR
- - Eric Sachetta view on EDGAR
- - Javier Rampolla view on EDGAR
- - Magdalena Martinez view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where SRTS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow SRTS with a 7-day demo
- SRTS on your watchlist
- Every SRTS Form 4 filing on record
- Up to 3 months of SRTS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
